GREENWOOD CAPITAL ASSOCIATES LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1161822 GREENWOOD, SC

Position in REGN

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$8,650,370

-$50,329 QoQ

Shares Held

13,873

+23.2% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

1.29%

of 13F equity value

Holder Rank

#315

of 1,322 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GREENWOOD CAPITAL ASSOCIATES LLC holds $17,673,711 across 9 Biotechnology names. REGN ranks #1 (48.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	13,873	$8,650,370
2	VRTX	Vertex Pharmaceuticals Inc / Ma	12,024	$5,972,681
3	HALO	Halozyme Therapeutics, Inc.	7,752	$606,749
4	KRYS	Krystal Biotech, Inc.	1,495	$555,646
5	EXEL	Exelixis, Inc.	8,152	$443,550
6	MDGL	Madrigal Pharmaceuticals, Inc.	773	$415,062
7	INCY	Incyte Corp	3,319	$376,241
8	CRSP	CRISPR Therapeutics AG	6,121	$333,839

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,650,370	13,873	+23.2%	Shares	Sole	2026-07-28
2026-03-31	$8,700,699	11,261	-2.3%	Shares	Sole	2026-04-29
2025-12-31	$8,898,117	11,528	-8.4%	Shares	Sole	2026-01-26
2025-09-30	$7,079,541	12,591	-2.1%	Shares	Sole	2025-10-16
2025-06-30	$6,752,025	12,861	+52.3%	Shares	Sole	2025-07-21
2025-03-31	$5,354,169	8,442	+50.0%	Shares	Sole	2025-04-15
2020-09-30	$3,151,001	5,629	-1.2%	Shares	Sole	2020-11-12
2020-06-30	$3,554,181	5,699	-40.4%	Shares	Sole	2020-08-12
2020-03-31	$4,670,982	9,566	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.